CAML is a p56Lck-interacting protein that is required for thymocyte development
about
Early aging-associated phenotypes in Bub3/Rae1 haploinsufficient mice.MUC1 mucin interacts with calcium-modulating cyclophilin ligand.RNF122: a novel ubiquitin ligase associated with calcium-modulating cyclophilin ligandCAML regulates Bim-dependent thymocyte death.WRB and CAML are necessary and sufficient to mediate tail-anchored protein targeting to the ER membrane.Endogenous galectin-1 enforces class I-restricted TCR functional fate decisions in thymocytes.Signaling defects in anti-tumor T cellsIdentification of calcium-modulating cyclophilin ligand as a human host restriction to HIV-1 release overcome by Vpu.The emerging role of calcium-modulating cyclophilin ligand in posttranslational insertion of tail-anchored proteins into the endoplasmic reticulum membrane.CAML mediates survival of Myc-induced lymphoma cells independent of tail-anchored protein insertion.Mice lacking WRB reveal differential biogenesis requirements of tail-anchored proteins in vivo.Calcium-modulating cyclophilin ligand regulates membrane trafficking of postsynaptic GABA(A) receptors.Yet another hump for CAML: support of cell survival independent of tail-anchored protein insertion.Cyclophilin and viruses: cyclophilin as a cofactor for viral infection and possible anti-viral target.Identification of a novel immunosubversion mechanism mediated by a virologue of the B-lymphocyte receptor TACI.CAML loss causes anaphase failure and chromosome missegregation.Essential role for CAML in follicular B cell survival and homeostasis.Effect of calcium-modulating cyclophilin ligand on human immunodeficiency virus type 1 particle release and cell surface expression of tetherinConditional deletion of calcium-modulating cyclophilin ligand causes deafness in mice.TMUB1 Inhibits BRL-3A Hepatocyte Proliferation by Interfering with the Binding of CAML to Cyclophilin B through its TM1 Hydrophobic Domain.
P2860
Q30480363-A46F5766-2E15-4488-954F-52C6D4C0CC6EQ33398890-DB818037-B181-401F-8A43-C1BF886F0CB3Q33606293-D3906D65-DC40-45A5-89B6-9F81B507469AQ33931340-B1FE0385-BE09-48FF-ACE7-68E9720FDBD6Q35083500-E699147E-2F0A-41F0-9DFB-9DABB0E36381Q36732791-625DF1CD-6F42-488A-B6F7-1101DE7874B9Q37063739-EB652D4F-39FF-4380-BA28-2E10B3A21143Q37120188-7B04376E-B811-4FFD-9F2F-1B6B1DF6BBB9Q38419066-D4EA85E5-6CDD-4B24-A75C-CCB05D6B500DQ38701281-A009DE25-3807-4C23-9DEA-BBEB30561001Q39612063-E4A5235D-B541-4829-A1C1-1F808F679956Q39990495-030746FA-D86D-4159-A0D7-45F39BE420BEQ41335539-345103E0-F918-42E8-B8F3-B8CC585EBEABQ42140198-016B6AA0-4D52-4CD2-9E71-117778D18A75Q42146978-8037CC8E-B832-4A25-8B5D-6F8393E10119Q42392589-7A4EED42-6D4F-45F1-A491-F0AB62603E32Q42568979-E1E29F3D-1BB3-4D31-84AE-708D53AF97A8Q42690322-33672631-55C2-47F0-99D9-1C9E0149B90EQ48777718-CE078B37-CC75-4CD2-801B-D52BF920CEFFQ55517627-DCE794E5-EC56-4785-9B1B-09285EB78F43
P2860
CAML is a p56Lck-interacting protein that is required for thymocyte development
description
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2005
@ast
im August 2005 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2005/08/01)
@sk
vědecký článek publikovaný v roce 2005
@cs
wetenschappelijk artikel (gepubliceerd op 2005/08/01)
@nl
наукова стаття, опублікована в серпні 2005
@uk
مقالة علمية (نشرت في أغسطس 2005)
@ar
name
CAML is a p56Lck-interacting protein that is required for thymocyte development
@ast
CAML is a p56Lck-interacting protein that is required for thymocyte development
@en
CAML is a p56Lck-interacting protein that is required for thymocyte development
@nl
type
label
CAML is a p56Lck-interacting protein that is required for thymocyte development
@ast
CAML is a p56Lck-interacting protein that is required for thymocyte development
@en
CAML is a p56Lck-interacting protein that is required for thymocyte development
@nl
prefLabel
CAML is a p56Lck-interacting protein that is required for thymocyte development
@ast
CAML is a p56Lck-interacting protein that is required for thymocyte development
@en
CAML is a p56Lck-interacting protein that is required for thymocyte development
@nl
P2093
P1433
P1476
CAML is a p56Lck-interacting protein that is required for thymocyte development
@en
P2093
Catherine J. Huntoon
Contessa E. Edgar
David D. Tran
David L. McKean
Jan van Deursen
Karin L. Heckman
Richard J. Bram
Shari L. Sutor
P304
P356
10.1016/J.IMMUNI.2005.06.006
P407
P577
2005-08-01T00:00:00Z